Lupus & antiphospholipid syndrome

Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project

Rheumatology (Oxford)Published Mixed methods study

Authors' conclusion

We found evidence indicating varying levels of direct attributability of both common and previously unexplored neuropsychiatric symptoms in SLE patients, with hallucinations and severe headache assessed as the most directly attributable.

Study context

Population
Systemic lupus erythematosus (SLE) patients, controls, inflammatory arthritis (IA) patients and clinicians in the international INSPIRE projectincluding 400 clinicians
Participants
2,817 patients
Comparison
SLE patients vs controls and IA patients
  • SLEn = 609
  • Controlsn = 463reference
  • IAn = 489
Outcome
Neuropsychiatric symptoms: prevalence and direct attributability to SLE
Methodological detailsinternational, quantitative and qualitative analysis
  • International
  • Quantitative and qualitative analysis

Main finding

As reported in the abstract

SLE patients reporting resolution/improvement of fatigue, positive sensory symptoms, severe headache and cognitive dysfunction with corticosteroids

Over 45%

Further findings

OutcomeP value
Severe headache, SLE vs IASLE vs IAP = 0.008
Severe headache, SLE vs IASLE vs IAP < 0.001

Neuropsychiatric symptoms relapsing/remitting with other disease symptoms (e.g. joint pain) in SLE and IA

Multiple neuropsychiatric symptoms relapsed/remitted with other disease symptoms such as joint pain

Qualitative: discussion of attributional evidence

Clinicians and patients reported insufficient time to discuss patient-reported attributional evidence
Symptoms viewed as indirectly related/non-attributable often less prioritized for discussion and treatment

Original publication

Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project. Rheumatology (Oxford). Published 22 March 2024. doi:10.1093/rheumatology/keae194

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.